Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Total Current Liabilities: 2014-2024

Historic Total Current Liabilities for KalVista Pharmaceuticals (KALV) over the last 8 years, with Apr 2024 value amounting to $22.8 million.

  • KalVista Pharmaceuticals' Total Current Liabilities was N/A to $26.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $26.1 million, marking a year-over-year change of. This contributed to the annual value of $22.8 million for FY2024, which is N/A change from last year.
  • As of FY2024, KalVista Pharmaceuticals' Total Current Liabilities stood at $22.8 million, which was up 195.43% from $7.7 million recorded in FY2020.
  • In the past 5 years, KalVista Pharmaceuticals' Total Current Liabilities ranged from a high of $22.8 million in FY2024 and a low of $7.7 million during FY2020.
  • In the last 1 years, KalVista Pharmaceuticals' Total Current Liabilities had a median value of $22.8 million in 2024 and averaged $22.8 million.
  • Data for KalVista Pharmaceuticals' Total Current Liabilities shows a maximum YoY tumbled of 57.23% (in 2020) over the last 5 years.
  • Over the past 2 years, KalVista Pharmaceuticals' Total Current Liabilities (Yearly) stood at $7.7 million in 2020, then followed by $22.8 million in 2024.